{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:35:54Z","timestamp":1780922154221,"version":"3.54.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To explore the relationship between different artificial reproductive treatment (ART) strategies and tumor outcomes, by analyzing clinical data of patients with endometrial carcinoma (EC) and atypical endometrial hyperplasia (AEH).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study was performed in a tertiary hospital. Patients (n=131) with EC or AEH, who underwent <jats:italic>in vitro<\/jats:italic> fertilization (IVF)\/intracytoplasmic sperm injection (ICSI) treatment between June 2010 and June 2021, were divided into a recurrence group and a non-recurrence group. Clinical characteristics and tumor outcomes were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>131 patients were followed up for 4-132 months; 33 patients had recurrence, the recurrence rate was 25.2%, 3-year recurrence-free survival (RFS) rate was 83.2 \u00b1 3.4%, and the 5-year RFS rate was 72.9 \u00b1 4.4%. Factors including the frequency of controlled ovarian stimulation (COS) and the total days of ovarian stimulation had no significant effect on the recurrence of tumor lesions (p=0.368 and 0.969, respectively). Histology type (HR: 4.94, 95%CI: 2.41-10.15, <jats:italic>p &amp;lt;<\/jats:italic>0.001) and successful\/un successful live birth (HR: 0.30, 95%CI: 0.14-0.65, <jats:italic>p<\/jats:italic>=0.003) were independent factors of recurrence. Twenty-two of the 82 patients who received a single COS had recurrence. Different COS protocols, the total dose of gonadotropin (Gn), and the serum E<jats:sub>2<\/jats:sub> level on the trigger day had no significant effect on recurrence (<jats:italic>p<\/jats:italic>=0.326, 0.889 and 0.468, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The degree at which an endometrial lesion progresses into carcinoma is a key factor affecting the recurrence of EC\/AEH in patients after IVF\/ICSI treatment, and successful live birth is a protective factor for the recurrence of endometrial lesions. Different COS protocols and COS frequencies, as well as the dosage and duration of Gn used during IVF did not affect the recurrence of endometrial lesions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.892995","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T12:04:42Z","timestamp":1656331482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment"],"prefix":"10.3389","volume":"12","author":[{"given":"Yaxing","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x","article-title":"The Behavior of Endometrial Hyperplasia. A Long-Term Study of \u201cUntreated\u201d Hyperplasia in 170 Patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.04.017","article-title":"Updates on Conservative Management of Endometrial Cancer in Patients Younger Than 45 Years","volume":"161","author":"Lucchini","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.11.018","article-title":"ESGO\/ESTRO\/ESP Guidelines for the Management of Patients With Endometrial Carcinoma","volume":"154","author":"Concin","year":"2021","journal-title":"Radiother Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/IJWH.S47232","article-title":"Preserving Fertility in Young Patients With Endometrial Cancer: Current Perspectives","volume":"6","author":"Kalogera","year":"2014","journal-title":"Int J Womens Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001164","article-title":"Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis","volume":"28","author":"Fan","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.12.1210","article-title":"Prognostic Impact of Hysteroscopic Resection of Endometrial Atypical Hyperplasia-Endometrioid Intraepithelial Neoplasia and Early-Stage Cancer in Combination With Megestrol Acetate","volume":"224","author":"Masciullo","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"474 e1","DOI":"10.1016\/j.ajog.2019.05.029","article-title":"National Patterns of Care and Fertility Outcomes for Reproductive-Aged Women With Endometrial Cancer or Atypical Hyperplasia","volume":"221","author":"Harrison","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.09.078","article-title":"Prognostic Factors of Oncological and Reproductive Outcomes in Fertility-Sparing Treatment of Complex Atypical Hyperplasia and Low-Grade Endometrial Cancer Using Oral Progestin in Chinese Patients","volume":"139","author":"Zhou","year":"2015","journal-title":"Gynecol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2011.02.001","article-title":"The Istanbul Consensus Workshop on Embryo Assessment: Proceedings of an Expert Meeting","volume":"26","year":"2011","journal-title":"Hum Reprod"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(00)00518-5","article-title":"Blastocyst Score Affects Implantation and Pregnancy Outcome: Towards a Single Blastocyst Transfer","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2017.08.016","article-title":"Effect of Repeated Cryopreservation on Human Embryo Developmental Potential","volume":"35","author":"Zheng","year":"2017","journal-title":"Reprod BioMed Online"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","article-title":"Factors Affecting Pregnancy Outcomes in Young Women Treated With Fertility-Preserving Therapy for Well-Differentiated Endometrial Cancer or Atypical Endometrial Hyperplasia","volume":"14","author":"Inoue","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem088","article-title":"Fertility-Preserving Treatment With Progestin, and Pathological Criteria to Predict Responses, in Young Women With Endometrial Cancer","volume":"22","author":"Yamazawa","year":"2007","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-014-0297-x","article-title":"The Outcome of Infertility Treatment in Patients Undergoing Assisted Reproductive Technology After Conservative Therapy for Endometrial Cancer","volume":"31","author":"Fujimoto","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/ijgc-2018-000036","article-title":"Pregnancy and Oncologic Outcomes After Fertility-Sparing Management for Early Stage Endometrioid Endometrial Cancer","volume":"29","author":"Chae","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31827c18a1","article-title":"The Influence of Infertility Treatment on the Prognosis of Endometrial Cancer and Atypical Complex Endometrial Hyperplasia","volume":"23","author":"Ichinose","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer Statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, Relapse, and Live Birth Rates With Fertility-Sparing Therapy for Endometrial Cancer and Atypical Complex Endometrial Hyperplasia: A Systematic Review and Metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2009.10.006","article-title":"Obstetric Outcomes of Pregnancy After Conservative Treatment of Endometrial Cancer: Case Series and Literature Review","volume":"50","author":"Chao","year":"2011","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12958-021-00808-y","article-title":"Analysis of Pregnancy-Associated Factors After Fertility-Sparing Therapy in Young Women With Early Stage Endometrial Cancer or Atypical Endometrial Hyperplasia","volume":"19","author":"Fan","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi084","article-title":"Uterine Cancer After Use of Clomiphene Citrate to Induce Ovulation","volume":"161","author":"Althuis","year":"2005","journal-title":"Am J Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605086","article-title":"Ovulation-Stimulation Drugs and Cancer Risks: A Long-Term Follow-Up of a British Cohort","volume":"100","author":"Silva Idos","year":"2009","journal-title":"Br J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.12.068","article-title":"Letrozole for Ovulation Induction and Fertility Preservation by Embryo Cryopreservation in Young Women With Endometrial Carcinoma","volume":"88","author":"Azim","year":"2007","journal-title":"Fertil Steril"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05513-6","article-title":"Mild Stimulation Protocol vs Conventional Controlled Ovarian Stimulation Protocol in Poor Ovarian Response Patients: A Prospective Randomized Controlled Trial","volume":"301","author":"Liu","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2010.532249","article-title":"Conservative Management of Young Patients With Endometrial Highly-Differentiated Adenocarcinoma","volume":"31","author":"Kalogiannidis","year":"2011","journal-title":"J Obstet Gynaecol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy Outcomes After Fertility-Sparing Management in Young Women With Early Endometrial Cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90148-5","article-title":"Endocrine and Paracrine Control of Oocyte Development","volume":"172","author":"Danforth","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-Term Oncologic Outcomes After Fertility-Sparing Management Using Oral Progestin for Young Women With Endometrial Cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.02024.x","article-title":"Fertility-Sparing Treatment in Young Women With Endometrial Cancer or Atypical Complex Hyperplasia: A Prospective Single-Institution Experience of 21 Cases","volume":"116","author":"Signorelli","year":"2009","journal-title":"BJOG"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.892995\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T12:04:44Z","timestamp":1656331484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.892995\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":30,"alternative-id":["10.3389\/fonc.2022.892995"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.892995","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"article-number":"892995"}}